UBS analyst Radi Sultan raised the firm’s price target on C3 AI (AI) to $28 from $26 and keeps a Neutral rating on the shares. C3 AI and Baker Hughes (BKR) announced the renewal and expansion of their joint venture agreement through mid-2028, while C3 guided fiscal 2026 revenue growth of 20% at the midpoint, the analyst tells investors in a research note. The renewal is a positive as this takes a key risk off the table, but the lack of visibility around revenue given the mix dynamic is the firm’s key hurdle to getting more constructive, the analyst says.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AI:
- Sell Rating on C3ai Due to Growth Concerns and Uncertain Long-term Benefits of Baker Hughes Contract
- C3.ai Faces Financial and Market Challenges Amidst AI Advancements: Analyst Recommends Sell Rating
- C3.ai Reports Record Growth and Strategic Partnerships
- Closing Bell Movers: Nvidia gains 4% on earnings, lifting other semis
- C3 AI sees FY26 revenue $447.5M-$484.5M consensus $466.1M